Neurology® Podcast cover image

Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

Neurology® Podcast

00:00

Is There a Business Model for All Timers Disease?

In the second half of this letter, you describe theb of all teimers disease. And jason, if i read this correctly, i think you're making the case that adican mab could be good or profitable, or a boost for infer structure of memory disorderd sinners. S what do you mean by that? You know, that if there isn't a way for the health care system to at least meet the meto break even, or even a little ahead, there's less enthusiasm for diagnosic and treating the disease. It is the case, i thinka, that a disease doesn't really fully exist until it has a business model.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app